Added to YB: 2025-12-30
Pitch date: 2025-12-29
BXN.AX [bullish]
Bioxyne Limited
Author Info
No bio for this author
Company Info
Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan.
Market Cap
AUD 92.0M
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
14.86
P/E
18.26
EV/Sales
2.92
Sector
Personal Care Products
Category
growth
The portfolio I am taking into 2026 - Bioxyne Limited
BXN.AX: GMP-certified B2B cannabis contract manufacturer (Foxconn model) in Australia/Germany/UK. No brand/marketing risk vs other cannabis stocks. FY26 guidance: 65-75M AUD revenue, 11.5-13.5M EBITDA (115-150% YoY growth). Trading 9x PE, 6-7x EV/EBITDA.
Read full article (1 min)